Canada markets closed

Revolution Medicines, Inc. (RVMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
39.19+0.37 (+0.95%)
At close: 04:00PM EDT
39.65 +0.46 (+1.17%)
After hours: 06:53PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.62B
Enterprise Value 4.85B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)379.32
Price/Book (mrq)3.62
Enterprise Value/Revenue 419.13
Enterprise Value/EBITDA -11.28

Trading Information

Stock Price History

Beta (5Y Monthly) 1.54
52-Week Change 360.21%
S&P500 52-Week Change 323.57%
52 Week High 339.60
52 Week Low 315.44
50-Day Moving Average 332.77
200-Day Moving Average 328.63

Share Statistics

Avg Vol (3 month) 31.5M
Avg Vol (10 day) 31.21M
Shares Outstanding 5170.49M
Implied Shares Outstanding 6164.69M
Float 8160.97M
% Held by Insiders 12.37%
% Held by Institutions 192.87%
Shares Short (Apr 15, 2024) 412.49M
Short Ratio (Apr 15, 2024) 47.78
Short % of Float (Apr 15, 2024) 47.87%
Short % of Shares Outstanding (Apr 15, 2024) 47.59%
Shares Short (prior month Mar 15, 2024) 416.4M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-20,819.81%

Management Effectiveness

Return on Assets (ttm)-20.08%
Return on Equity (ttm)-34.75%

Income Statement

Revenue (ttm)11.58M
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)-95.20%
Gross Profit (ttm)N/A
EBITDA -456.68M
Net Income Avi to Common (ttm)-436.37M
Diluted EPS (ttm)-3.86
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.85B
Total Cash Per Share (mrq)11.25
Total Debt (mrq)87.94M
Total Debt/Equity (mrq)4.82%
Current Ratio (mrq)13.06
Book Value Per Share (mrq)11.09

Cash Flow Statement

Operating Cash Flow (ttm)-350.57M
Levered Free Cash Flow (ttm)-155.2M